Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | https://onlinelibrary.wiley.com/doi/10.1002/cpu30890 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Sommario:
- Prescribe for patients with opioid use disorder — with confidence Alison Knopf The Brown University Child & Adolescent Psychopharmacology Update A new message from the Food and Drug Administration (FDA) encourages primary care providers to prescribe medication — primarily, buprenorphine — for opioid use disorder (OUD) “with confidence.” In the missive, subtitled “Patients with opioid use disorder need you,” the FDA noted that more than 6 million people age 12 or older have an OUD. Below is the FDA statement. 10.1002/cpu30890 http://onlinelibrary.wiley.com/termsAndConditions#vor